Novo Signs Up Another Oral Insulin Partner, Hedging Its Bets
This article was originally published in The Pink Sheet Daily
Executive Summary
Novo Nordisk places another oral insulin technology bet with Emisphere; expands partnership with Merrion beyond insulin.